Skip to content

Nutrients and Hormones: Effects in Boys With Disordered Growth

Nutrients and Hormones: Effects in Boys With Disordered Growth

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00139451
Enrollment
20
Registered
2005-08-31
Start date
2004-05-31
Completion date
2010-09-30
Last updated
2011-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Constitutional Growth Delay, Nutrition Disorders, Growth Disorders

Keywords

GH, Delayed Growth, Energy Expenditure, Puberty, Nutrition, Short Stature

Brief summary

The purpose of the study is to find out if patients with constitutional delay of growth have a mismatch between energy intake and utilization (as measured by doubly labeled water) and to compare the improvement in growth and energy balance between a group of boys treated with growth hormone (GH) alone versus those given GH plus added nutritional supplements for one year.

Detailed description

Two groups of boys 7-10 years old who are very short and below average in weight but otherwise healthy will be studied. One group will be observed initially for 6 months and then receive GH injections every day for the subsequent 12 months. Another group of boys will get a high-calorie drink every day for 6 months, and then receive GH injections plus the supplement every day for the next 12 months. We will compare how well boys grow in height, weight and the changes in body composition. We will compare diet and energy usage using the doubly labeled water technique. A battery of hormonal and nutritional tests will be performed, as well as body composition assessment.

Interventions

With the assistance of a research dietician, we will prescribe and monitor the use of a liquid food supplement (Pediasure). Adjustments to the supplementation will be made based on weight measurements in the clinic with subjects wearing paper gowns at 2 and 4w, and monthly thereafter, and repeat dietary intake and TEE assessment at 6 and 12mo.

DRUGGH

Growth Hormone will be 0.3mg/kg/week, given SC once daily.

Sponsors

Genentech, Inc.
CollaboratorINDUSTRY
Nemours Children's Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
7 Years to 10 Years
Healthy volunteers
No

Inclusion criteria

* Boys 7-10 years old who are very short and below average in weight but otherwise healthy. * Delay in skeletal maturation \> 1 year.

Exclusion criteria

* Growth hormone deficiency * Chronic illness * Participation in high endurance athletics

Design outcomes

Primary

MeasureTime frame
Change in height, weight, and body composition6month, 12month, 18month

Secondary

MeasureTime frame
Changes in total energy expenditure6month, 12month

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026